LKQ Corporation (LKQ) SEC Filings & Earnings Calls
EquiReason read 15 LKQ Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-10-23 — CEO Justin Jude and Europe head Andy Hamilton terminated; Salvatore Abbate appointed CEO effective Dec 15, 2026; Alvarez & Marsal retained for European operations; full-year 2026 g.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 4.4B
- P/E TTM
- 9.7
- Dividend yield
- 7.0%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
23 Oct 20268-K · 2.02, 5.02, 7.01CEO Justin Jude and Europe head Andy Hamilton terminated; Salvatore Abbate appointed CEO effective Dec 15, 2026; Alvarez & Marsal retained for European operations; full-year 2026 guidance withdrawn; preliminary Q3 revenue $3.32B, organic reopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $3.32B | -5% y/y |
| Parts and services organic revenue decline · Q3-2026 | 5.4% | |
| Europe parts and services organic revenue decline · Europe · Q3-2026 | 9.8% | |
| Non-cash impairment charges · Q3-2026 | $111M |
Guidance
Full-year 2026 guidance withdrawn
Guidance withdrawn due to Europe underperformance and leadership change
Risks flagged
Significant underperformance in Europe with operational disruptions
“operational disruptions associated with the ERP implementation in Germany and volume declines in the United Kingdom and Benelux” · word for word
Guidance withdrawn, increasing uncertainty
“The Company is also withdrawing its full-year 2026 guidance” · word for word
Leadership instability with CEO and Europe head departures
“Justin Jude departing; Andy Hamilton departing”
30 Jul 20268-K · 2.02Revenue $3.40B (-3% y/y); Net income $134M; Diluted earnings per share $0.52; Guidance: Organic revenue growth: (0.5%-1.5%) to (3.0%-(1.0%)); Adjusted EPS: $2.90-$3.20 to $2.60-$2.90earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $3.40B | -3% y/y |
| Net income · Q2-2026 | $134M | |
| Diluted earnings per share · Q2-2026 | $0.52 | |
| Adjusted diluted EPS · Q2-2026 | $0.67 | |
| Operating cash flow · Q2-2026 | $111M | |
| Free cash flow · Q2-2026 | $60M |
Guidance
Organic revenue growth: (0.5%-1.5%) to (3.0%-(1.0%)); Adjusted EPS: $2.90-$3.20 to $2.60-$2.90
Full-year 2026 guidance cut across all metrics due to slower recovery in Europe and ERP disruption.
Risks flagged
ERP implementation in Germany causing significant disruption to European operations, leading to lower volumes and financial underperformance.
“Europe fell short of expectations, with results affected by the ERP implementation in Germany” · word for word
Strategic review process introduces uncertainty; potential sale of Specialty segment or entire company could impact operations.
“The Company announced that it had commenced a process to explore a potential sale of its Specialty segment ... and ... a comprehensive review of strategic alternatives, including a sale of the Company” · word for word
30 Jul 202610-QLKQ reported Q2 2026 revenue of $3.41B (-3% YoY) and operating income of $225M (-25% YoY), with significant weakness in Europe and a $44M impairment on Mekonomen investment.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $3.41B | -3% y/y |
| Net income · Q2-2026 | $136M | -30% y/y |
| Operating cash flow · H1-2026 | $55M | -81% y/y |
| North America segment revenue · North America · Q2-2026 | $1.37B | +1% y/y |
| Europe segment revenue · Europe · Q2-2026 | $1.45B | -10% y/y |
| Specialty segment revenue · Specialty · Q2-2026 | $487M | +5% y/y |
| Provision for credit losses · H1-2026 | $26M | +271% y/y |
| Impairment on Mekonomen equity method investment · Europe · Q1-2026 | $44M |
Risks flagged
Europe segment revenue decline
“Europe segment revenue declined 10% year-over-year in Q2 2026.”
Credit loss deterioration
“Provision for credit losses increased to $26M in H1 2026 from $7M in H1 2025.”
Litigation risk
“Securities class action and derivative lawsuits filed alleging misleading statements regarding Uni-Select acquisition.”
Equity method investment impairment
“Recognized a $44 million impairment on Mekonomen investment due to financial condition and stock price decline.”
30 Apr 20268-K · 2.02Q1 2026 revenue up 4.3% to $3,469M but net income fell to $77M from $158M; adjusted EPS down 9.5% to $0.67; guidance cut for diluted EPS to $2.16-$2.46 from $2.35-$2.65; strategic review initiated.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $3.47B | +4% y/y |
| Net income · Q1-2026 | $77M | -51% y/y |
| Diluted earnings per share · Q1-2026 | $0.30 | -51% y/y |
| Adjusted diluted earnings per share · Q1-2026 | $0.67 | -9% y/y |
| Free cash flow · Q1-2026 | $-96M | +68% y/y |
| Operating cash flow · Q1-2026 | $-56M | +1767% y/y |
Guidance
FY26 organic revenue growth (0.5%) to 1.5% unchanged; FY26 diluted EPS cut to $2.16-$2.46 from $2.35-$2.65; FY26 adjusted diluted EPS $2.90-$3.20 unchanged; FY26 operating cash flow $900-$1,100M unchanged; FY26 free cash flow $700-$850M unchanged; FY26 capex $200-$250M
Reaffirmed most guidance but cut diluted EPS; management cites challenging environment but improving trends.
Risks flagged
Impairment of equity method investment in Mekonomen of $44M
“Net income 2 for the three months ended March 31, 2026 included a $44 million (or $0.17) impairment of our equity method investment in Mekonomen.” · word for word
Negative free cash flow in Q1 2026
“Cash flow from operations 3 and free cash flow 1,3 were negative $56 million and negative $96 million, respectively, for the first quarter of 2026.” · word for word
Guidance cut for diluted EPS
“Diluted EPS 2 $2.35 to $2.65 $2.16 to $2.46” · word for word
30 Apr 202610-QRevenue $3.47B (+4% y/y); Net income $79M (-53% y/y); Operating cash flow $-56Mopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $3.47B | +4% y/y |
| Net income · Q1-2026 | $79M | -53% y/y |
| Operating cash flow · Q1-2026 | $-56M | |
| Segment EBITDA - North America · North America · Q1-2026 | $203M | -7% y/y |
| Segment EBITDA - Europe · Europe · Q1-2026 | $126M | -11% y/y |
| Segment EBITDA - Specialty · Specialty · Q1-2026 | $18M | -14% y/y |
| Gross margin · Q1-2026 | $1.33B | +1% y/y |
| Diluted EPS from continuing operations · Q1-2026 | $0.30 | -51% y/y |
Risks flagged
Equity method investment impairment
“Recognized an other-than-temporary impairment of $44 million on Mekonomen investment due to significant increase in leverage ratio, dividend discontinuation, and prolonged stock price decrease” · word for word
Specialty segment sale risk
“Specialty reporting unit fair value exceeded carrying value by only 11% as of March 31, 2026, indicating limited headroom”
Securities class action lawsuit
“On April 22, 2026, a purported stockholder filed a putative class action alleging materially false and misleading statements regarding Uni-Select acquisition and integration” · word for word
Operating cash flow deterioration
“Net cash used in operating activities worsened to $56 million from $3 million in prior year Q1”
24 Mar 2026DEF 14AProxy statement filed for the 2026 Annual Meeting, including proposals to elect directors, ratify auditor, advisory vote on executive compensation, and approve an amendment to allow stockholders holding 25% or more of common stock to requesopen
Figures in the filing · each found in the filing text
| EBITDA · Corporate · FY2025 | $1.54B | |
| EBITDA Margin · Corporate · FY2025 | 11.2% | |
| Free Cash Flow · Corporate · FY2025 | $921M | |
| Adjusted Diluted EPS · FY2025 | $3.11 | |
| GAAP Net Income · FY2025 | $608M | |
| Total Shareholder Return (Cumulative) · 2021-2025 | $95.00 | |
| Peer Group Total Shareholder Return (Cumulative) · 2021-2025 | $80.00 | |
| CEO Total Compensation · FY2025 | $9M | |
| Median Employee Total Compensation · FY2025 | $48190.00 | |
| CEO Pay Ratio · FY2025 | $182.00 |
19 Feb 20268-K · 2.02Revenue $3.30B (+3% y/y); Net income $75M (-50% y/y); Adjusted diluted earnings per share $0.59 (-24% y/y); Guidance: 2026 outlook provided; restructuring plan to generate $50M+ annualized savingsearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q4-2025 | $3.30B | +3% y/y |
| Net income · Q4-2025 | $75M | -50% y/y |
| Adjusted diluted earnings per share · Q4-2025 | $0.59 | -24% y/y |
| Operating cash flow · FY2025 | $1.10B | |
| Free cash flow · FY2025 | $847M | |
| Revenue · FY2025 | $13.70B | -1% y/y |
| Net income · FY2025 | $596M | -11% y/y |
| Adjusted diluted earnings per share · FY2025 | $3.01 | -11% y/y |
| Parts and services organic revenue growth · Q4-2025 | -1.7% | |
| Specialty organic revenue growth · Specialty · Q4-2025 | 7.8% |
Guidance
2026 outlook provided; restructuring plan to generate $50M+ annualized savings
2026 outlook reflects continued sector headwinds; restructuring plan aims to improve cost structure; strategic review adds uncertainty
Risks flagged
Sector headwinds in Europe and soft demand in North America
“sector headwinds across our global enterprise... soft demand environment”
Restructuring execution risk
“restructuring plan intended to better position our cost structure... charges of approximately $60 to $70 million” · word for word
Strategic review outcome uncertainty
“comprehensive review of strategic alternatives... no assurance the review will result in any transaction”
26 Jan 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Strategic review could lead to sale, merger, or other structural change; uncertainty for shareholders.
“Comprehensive review of strategic alternatives announced.”
18 Dec 20258-K · 1.01, 2.03, 8.01Entered a material definitive agreement (acquisition, partnership, or major contract); took on a material direct financial obligation, increasing leverageopen
Risks flagged
No material risk; amendments are favorable to company.
4 Dec 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Divestiture process introduces execution risk and potential disruption
“explore the potential sale of its Specialty segment” · word for word
4 Nov 20258-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Loss of board experience, but no material risk given single director departure.
“Director departure, no other details provided.”
30 Oct 20258-K · 2.02Revenue $3.50B (+1% y/y); Net income (continuing ops) $178M (-5% y/y); Adjusted net income (continuing ops) $216M (-4% y/y); Guidance: Organic revenue growth guidance narrowed to (3.0%) to (2.0%) from (3.5%) to (1.5%); EPS outlook raisedearningsopen
Figures in the filing · each found in the filing text
| Revenue · consolidated · Q3-2025 | $3.50B | +1% y/y |
| Net income (continuing ops) · consolidated · Q3-2025 | $178M | -5% y/y |
| Adjusted net income (continuing ops) · consolidated · Q3-2025 | $216M | -4% y/y |
| Diluted EPS (continuing ops) · consolidated · Q3-2025 | $0.69 | -3% y/y |
| Adjusted diluted EPS (continuing ops) · consolidated · Q3-2025 | $0.84 | -2% y/y |
| Cash flow from operations · consolidated · Q3-2025 | $440M | |
| Free cash flow · consolidated · Q3-2025 | $387M | |
| Total debt · consolidated · 2025-09-30 | $4.20B | |
| Total leverage (EBITDA) · consolidated · 2025-09-30 | $2.50 | |
| Share repurchases (Q3) · consolidated · Q3-2025 | $40M |
Guidance
Organic revenue growth guidance narrowed to (3.0%) to (2.0%) from (3.5%) to (1.5%); EPS outlook raised
Raised midpoint and narrowed full-year 2025 EPS outlook following Self Service divestiture; organic revenue guidance slightly improved.
Risks flagged
Organic revenue decline in parts & services; North American organic per day down 30bps despite 6% decline in repairable claims.
“North American organic revenue on a per day basis decreased 30 basis points against the backdrop of a 6% decline in repairable claims.” · word for word
30 Oct 202510-QLKQ reported Q3 2025 revenue of $3,499M (+1.3% YoY) and net income of $180M (-5.8% YoY), with mixed segment performance and completion of Self Service sale.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $3.50B | +1% y/y |
| Gross margin · Q3-2025 | $1.34B | +0% y/y |
| Operating income · Q3-2025 | $274M | -8% y/y |
| Net income attributable to LKQ stockholders · Q3-2025 | $180M | -6% y/y |
| Diluted EPS from continuing operations · Q3-2025 | $0.69 | -3% y/y |
| Operating cash flow · 9M-2025 | $733M | -17% y/y |
| Capex · 9M-2025 | $160M | -29% y/y |
| Wholesale North America revenue · Wholesale - North America · Q3-2025 | $1.34B | -0% y/y |
| Europe revenue · Europe · Q3-2025 | $1.61B | +0% y/y |
| Specialty revenue · Specialty · Q3-2025 | $456M | +9% y/y |
Risks flagged
Restructuring execution risk
“2024 Global Restructuring Plan estimated total cost ~$140M, with $133M incurred as of Q3 2025; plan substantially complete by end of 2025.”
Commodity price exposure
“Sale of Self Service segment to reduce exposure to commodity price changes; segment was asset-intensive and heavily affected by commodity prices.”
Debt refinancing risk
“Current portion of long-term obligations $537M as of September 30, 2025, up from $38M at December 31, 2024, due to revolving credit facility borrowings.”
LKQ Corporation — questions
- What did LKQ Corporation file recently?
- 15 SEC filings in the last 12 months. Latest: 8-K on 2026-10-23 — CEO Justin Jude and Europe head Andy Hamilton terminated; Salvatore Abbate appointed CEO effective Dec 15, 2026; Alvarez & Marsal retained for European operations; full-year 2026 guidance withdrawn; preliminary Q3 revenue $3.32B, organic re
Every figure on this page comes from LKQ Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.